All
C3i
Life Sciences

Drug Safety/ Pharmacovigilance & Social Media

Bart Cobert / Apr 15, 2014

Time to look again at the status of social media and its impact on drug safety. Unlike many other areas in life, the internet and social media have not yet[…]

FDA Issues Social Media Guidance for Pharma

C3i Solutions / Jan 17, 2014

If you own “it,” finance “it” or influence “it” you are responsible for “it.” In essence that’s what the FDA recently said in their draft guidance on “Fulfilling Regulatory Requirements[…]

Take a Step Back and Look. The World is Changing Around You.

C3i Solutions / Nov 22, 2013

We are often too busy to have the time to take a step back and see what is going on around us. There are macroeconomic, demographic, social and climate trends[…]

Collecting Adverse Events with Social Media

Bart Cobert / Jul 17, 2013

Social media as a tool for improving drug safety is now an old idea (“old” in the world of social media means more than a year ago). We have seen[…]

The UK’s Association of the British Pharmaceutical Industry’s Guidance on AEs & Product Complaints from Social Media

Bart Cobert / May 01, 2013

https://www.abpi.org.uk/our-work/library/guidelines/Pages/safety-data-websites.aspx Background The Association of the British Pharmaceutical Industry (ABPI) has just released an updated guidance on how companies should handle adverse events (AEs) and product complaints (PCs) derived from[…]

Social CRM in Healthcare: New millennial challenges in a ponderous regulatory environment

Barry Peters / May 03, 2011

This is an excerpt from an article printed in SOCAP CRM Magazine found here. The article was co-authored by Steve DeLabio, Strategic & Analytic Consulting, Epsilon. As marketers in the[…]